131 related articles for article (PubMed ID: 27028361)
1. Dermatological aspects of synthetic cannabinoid addiction.
Inci R; Kelekci KH; Oguz N; Karaca S; Karadas B; Bayrakci A
Cutan Ocul Toxicol; 2017 Jun; 36(2):125-131. PubMed ID: 27028361
[TBL] [Abstract][Full Text] [Related]
2. A survey of synthetic cannabinoid consumption by current cannabis users.
Gunderson EW; Haughey HM; Ait-Daoud N; Joshi AS; Hart CL
Subst Abus; 2014; 35(2):184-9. PubMed ID: 24821356
[TBL] [Abstract][Full Text] [Related]
3. Skin diseases associated with the cosmetic use of bleaching products in women from Dakar, Senegal.
Mahé A; Ly F; Aymard G; Dangou JM
Br J Dermatol; 2003 Mar; 148(3):493-500. PubMed ID: 12653741
[TBL] [Abstract][Full Text] [Related]
4. [Side effects of oral contraceptives from a dermatological viewpoint].
Marghescu S
Ther Ggw; 1979 Aug; 118(8):1230-43. PubMed ID: 158843
[No Abstract] [Full Text] [Related]
5. Synthetic Cannabinoids: Use and Predictors in a Community Sample of Young Adults.
Caviness CM; Tzilos G; Anderson BJ; Stein MD
Subst Abus; 2015; 36(3):368-73. PubMed ID: 25222129
[TBL] [Abstract][Full Text] [Related]
6. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
[TBL] [Abstract][Full Text] [Related]
7. [Synthetic cannabinoids: A new addiction matrix].
Scocard A; Benyamina A; Coscas S; Karila L
Presse Med; 2017 Jan; 46(1):11-22. PubMed ID: 28063756
[TBL] [Abstract][Full Text] [Related]
8. Assessing the experience of using synthetic cannabinoids by means of interpretative phenomenological analysis.
Kassai S; Pintér JN; Rácz J; Böröndi B; Tóth-Karikó T; Kerekes K; Gyarmathy VA
Harm Reduct J; 2017 Feb; 14(1):9. PubMed ID: 28187774
[TBL] [Abstract][Full Text] [Related]
9. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl.
Zímová J; Zímová P
Acta Dermatovenerol Croat; 2016 Jun; 24(2):150-3. PubMed ID: 27477178
[TBL] [Abstract][Full Text] [Related]
10. International trends in spice use: Prevalence, motivation for use, relationship to other substances, and perception of use and safety for synthetic cannabinoids.
Loeffler G; Delaney E; Hann M
Brain Res Bull; 2016 Sep; 126(Pt 1):8-28. PubMed ID: 27108542
[TBL] [Abstract][Full Text] [Related]
11. [Cutaneous complications of estro-progestative agents: statistical study. Apropos of 562 users].
Dugois P; Amblard P; Manent J; Deshors G
Ann Dermatol Syphiligr (Paris); 1971; 98(5):479-86. PubMed ID: 4259026
[No Abstract] [Full Text] [Related]
12. Dermatological, medical, and laboratory findings of patients in Taiwan and their treatments.
Lü YC; Wong PN
Am J Ind Med; 1984; 5(1-2):81-115. PubMed ID: 6230932
[TBL] [Abstract][Full Text] [Related]
13. Characteristics associated with synthetic cannabinoid use among patients treated in a public psychiatric emergency setting.
Joseph AM; Manseau MW; Lalane M; Rajparia A; Lewis CF
Am J Drug Alcohol Abuse; 2017 Jan; 43(1):117-122. PubMed ID: 27797288
[TBL] [Abstract][Full Text] [Related]
14. Designer drugs. Patients may be using synthetic cannabinoids more than you think.
Lisi DM
JEMS; 2014 Sep; 39(9):56-9. PubMed ID: 25322519
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous side effects of oral contraceptives.
Jelinek JE
Arch Dermatol; 1970 Feb; 101(2):181-6. PubMed ID: 4244175
[No Abstract] [Full Text] [Related]
16. PCB poisoning in Japan and Taiwan. Dermatological, medical, and laboratory findings of patients in Taiwan and their treatments.
Lü YC; Wong PN
Prog Clin Biol Res; 1984; 137():81-115. PubMed ID: 6232617
[TBL] [Abstract][Full Text] [Related]
17. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
Besli GE; Ikiz MA; Yildirim S; Saltik S
J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
[TBL] [Abstract][Full Text] [Related]
18. Skin stigmata of adolescent drug addiction.
Young AW; Digrande EV; Wagers LT
Mod Treat; 1972 Feb; 9(1):117-36. PubMed ID: 5029630
[No Abstract] [Full Text] [Related]
19. Uses, Effects and Toxicity of Synthetic Cannabinoids from the Perspective of People with Lived Experiences.
Assi S; Marshall D; Bersani FS; Corazza O
J Psychoactive Drugs; 2020; 52(3):237-247. PubMed ID: 32027228
[TBL] [Abstract][Full Text] [Related]
20. [Dermatological symptoms of yusho. Alterations in this decade (author's transl)].
Asahi M; Koda H; Urabe H; Toshitani S
Fukuoka Igaku Zasshi; 1979 Apr; 70(4):172-80. PubMed ID: 157970
[No Abstract] [Full Text] [Related]
[Next] [New Search]
